2 - 2 |
Particles provoke immune response (vol 96, pg 6, 2018) Scott A |
2 - 2 |
Sanofi buys into Denali's RIPK1 drugs (vol 96, pg 13, 2018) Reisch MS |
2 - 2 |
THE LONG ROAD TO RELIEF (vol 96, pg 29, 2018) Nguyen T |
2 - 2 |
Liquid from water Birkett J |
3 - 3 |
Luis Echegoyen is 2019 ACS president-elect Echegoyen LA |
4 - 4 |
Genomics effort yields antiparasite targets Satyanarayana M |
4 - 4 |
Electrochemistry could explain Mars's organics Lemonick S |
6 - 6 |
Protein selectively captures lanthanides Peplow M |
7 - 7 |
Soft electrodes cozy up to cells Bourzac K |
8 - 8 |
Hundreds of pollutants found in polar bears' blood Peplow M |
8 - 9 |
Spurring STING into action systemically Halford B |
8 - 8 |
Common pesticide impairs bees' social behavior Bourzac K |
9 - 9 |
Uranium dimer loses a bond Lemonick S |
9 - 9 |
Patch delivers drugs to eye Arnaud C |
9 - 9 |
Lipid chains yield potential antibiotics Arnaud C |
10 - 10 |
Firms invest in human milk oligosaccharides Bomgardner M |
10 - 10 |
New firm gets help from BASF Tullo A |
11 - 11 |
Illumina to buy Pacific Biosciences Reisch M |
12 - 12 |
Profits continue to rise in Japan Tremblay JF |
14 - 14 |
Evonik will acquire PeroxyChem McCoy M |
14 - 14 |
FMC's Brondeau to get Palladium Medal Reisch M |
14 - 14 |
UK eyes agrotech hub Scott A |
14 - 14 |
Praxair will boost gases for space market McCoy M |
14 - 15 |
Evonik expands its presence on the farm McCoy M |
14 - 14 |
Former BioAmber site to get new life Bomgardner M |
14 - 14 |
Orion buys Lyondell carbon black plant Tullo A |
15 - 15 |
Janssen licenses cancer drug from Yuhan Cross R |
15 - 15 |
Regenxbio gets $40 million for AAV9 Cross R |
15 - 15 |
Regulus and Sanofi amend microRNA pact Jarvis LM |
15 - 15 |
WeylChem acquires Unilever catalyst line Mullin R |
15 - 15 |
Symrise, IBM use Al for fragrance design Reisch M |
17 - 17 |
Changes ahead with new US Congress Erickson B, Johnson J, Kemsley J |
18 - 24 |
Controversy highlights flaws of UK research integrity system Lack of transparency in single-molecule magnet case and others could undermine public trust in research, experts say Peplow M |
25 - 28 |
Have antisense oligonucleotides hit their stride? After 40 years, the drug class looks poised to finally fulfill the promise of rapid development and enter a new era of personalized medicine Cross R |
29 - 30 |
Hovione bulks up, with a twist A pharmaceutical services pioneer cues up continuous tableting as it doubles manufacturing Mullin R |
31 - 31 |
Up from the basement Diane Villax, Hovione's still-active matriarch, recounts the rise of a pioneer in pharmaceutical chemical services Mullin R |
33 - 33 |
EU copyright reforms get mixed response Final vote expected in early 2019 Dupraz-Dobias P |
34 - 35 |
C&EN talks with Anne McNeil, diversity champion Founder of Diversify Chemistry explains why she started the online directory of academic chemists from underrepresented groups Wang LD |
36 - 40 |
Making biologics on demand Arnaud CH |
42 - 42 |
How will you collaborate in 2019? Charpentier BA |
43 - 43 |
Project SEED scholars Elaine Gomez and Luis Mendez Wang LD |
44 - 44 |
Bernard Hofreiter Obituary Hart A |
44 - 44 |
John C. Koenig Obituary Williams L |
44 - 44 |
Ernest W. Robb Obituary Robb J |
44 - 44 |
Robert E. Plapinger Obituary O'Niell JJ |
44 - 44 |
Henry T. Hoffman Obituary Hoffman TH |
44 - 44 |
Margareta Lambert Obituary Heineman P |
48 - 48 |
Pocket resistance Marshall J |
48 - 48 |
Lab-friendly fashion Marshall J |